Insmed Inc (INSM)vsVanda Pharmaceuticals Inc (VNDA)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
VNDA
Vanda Pharmaceuticals Inc
$7.25
+6.30%
HEALTHCARE · Cap: $403.12M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 181% more annual revenue ($606.42M vs $216.10M). INSM leads profitability with a -2.1% profit margin vs -102.0%. INSM appears more attractively valued with a PEG of 1.09. VNDA earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
VNDA
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Reasonable price relative to book value
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Expensive relative to growth rate
Smaller company, higher risk/reward
ROE of -50.9% — below average capital efficiency
Earnings declined 95.9%
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : VNDA
The strongest argument for VNDA centers on Price/Book.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : VNDA
The primary concerns for VNDA are PEG Ratio, Market Cap, Return on Equity.
Key Dynamics to Monitor
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
VNDA is growing revenue faster at 7.6% — sustainability is the question.
VNDA generates stronger free cash flow (-30M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
INSM scores higher overall (39/100 vs 39/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Vanda Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?